Wachtell K - Search Results

1

Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).

Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K. Greve AM, et al. Among authors: wachtell k. Am J Cardiol. 2014 Sep 1;114(5):751-6. doi: 10.1016/j.amjcard.2014.06.006. Epub 2014 Jun 21. Am J Cardiol. 2014. PMID: 25048345 Clinical Trial.

2

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.

Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlöf B, Aalto T, Roman MJ, Papademetriou V, Ibsen H, Rokkedal J, Devereux RB. Wachtell K, et al. Hypertension. 2000 Jan;35(1 Pt 1):6-12. doi: 10.1161/01.hyp.35.1.6. Hypertension. 2000. PMID: 10642267

3

Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.

Wachtell K, Smith G, Gerdts E, Dahlöf B, Nieminen MS, Papademetriou V, Bella JN, Ibsen H, Rokkedal J, Devereux RB. Wachtell K, et al. Am J Cardiol. 2000 Feb 15;85(4):466-72. doi: 10.1016/s0002-9149(99)00773-0. Am J Cardiol. 2000. PMID: 10728952 Clinical Trial.

4

Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension.

Devereux RB, Roman MJ, Palmieri V, Okin PM, Boman K, Gerdts E, Nieminen MS, Papademetriou V, Wachtell K, Dahlöf B. Devereux RB, et al. Among authors: wachtell k. J Hypertens. 2000 Aug;18(8):1129-38. doi: 10.1097/00004872-200018080-00019. J Hypertens. 2000. PMID: 10954006 Clinical Trial.

5

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.

Wachtell K, Rokkedal J, Bella JN, Aalto T, Dahlöf B, Smith G, Roman MJ, Ibsen H, Aurigemma GP, Devereux RB. Wachtell K, et al. Am J Cardiol. 2001 Jan 1;87(1):54-60. doi: 10.1016/s0002-9149(00)01272-8. Am J Cardiol. 2001. PMID: 11137834

6

Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study.

Bella JN, Wachtell K, Palmieri V, Liebson PR, Gerdts E, Ylitalo A, Koren MJ, Pedersen OL, Rokkedal J, Dahlöf B, Roman MJ, Devereux RB. Bella JN, et al. Among authors: wachtell k. J Hypertens. 2001 Jan;19(1):127-34. doi: 10.1097/00004872-200101000-00017. J Hypertens. 2001. PMID: 11204292

7

Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.

Palmieri V, Wachtell K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, Nieminen MS, Dahlöf B, de Simone G, Devereux RB. Palmieri V, et al. Among authors: wachtell k. Am Heart J. 2001 May;141(5):784-91. doi: 10.1067/mhj.2001.114803. Am Heart J. 2001. PMID: 11320367 Clinical Trial.

8

Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study.

Devereux RB, Bella J, Boman K, Gerdts E, Nieminen MS, Rokkedal J, Papademetriou V, Wachtell K, Wright J, Paranicas M, Okin PM, Roman MJ, Smith G, Dahlöf B. Devereux RB, et al. Among authors: wachtell k. Blood Press. 2001;10(2):74-82. doi: 10.1080/08037050152112050. Blood Press. 2001. PMID: 11467763

9

Papademetriou V, Devereux RB, Narayan P, Wachtell K, Bella JN, Gerdts E, Chrysant SG, Dahlöf B. Papademetriou V, et al. Among authors: wachtell k. Am J Hypertens. 2001 Aug;14(8 Pt 1):768-74. doi: 10.1016/s0895-7061(01)01292-4. Am J Hypertens. 2001. PMID: 11497192 Clinical Trial.

10

Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension.

Olsen MH, Wachtell K, Aalkjaer C, Devereux RB, Dige-Petersen H, Ibsen H. Olsen MH, et al. Among authors: wachtell k. Am J Hypertens. 2001 Sep;14(9 Pt 1):861-7. doi: 10.1016/s0895-7061(01)02148-3. Am J Hypertens. 2001. PMID: 11587150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page